| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $2.7B | $2.8B | $3.0B | $3.3B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $0.7B | $0.8B | $0.8B | $0.6B |
| Operating Income | $-0.9B | $-2.0B | $0.1B | $0.8B |
| Net Income | $-1.1B | $-2.1B | $-0.0B | $0.5B |
| EPS (Basic) | $-16.69 | $-30.54 | $-0.15 | $9.66 |
| EPS (Diluted) | $-16.69 | $-30.54 | $-0.15 | $9.56 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $5.8B | $6.4B | $8.6B | $8.9B |
| Current Assets | $1.4B | $1.2B | $1.3B | $1.6B |
| Cash & Equivalents | $0.2B | $0.1B | $0.1B | $0.3B |
| Total Liabilities | $3.8B | $3.4B | $3.6B | $3.9B |
| Current Liabilities | $1.0B | $1.0B | $0.8B | $1.0B |
| Stockholders' Equity | $1.9B | $3.0B | $5.0B | $4.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.3B | $0.9B |
| Investing Cash Flow | $-0.2B | $-0.1B | $-0.2B | $-1.6B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $0.2B | $0.0B | $-0.3B | $0.3B |